oleanolic acid has been researched along with Alport Syndrome in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukiya, H; Horizono, J; Kai, H; Kamura, M; Kaseda, S; Koyama, Y; Kuwazuru, J; Nara, F; Niinou, S; Nishiyama, H; Ogi, S; Onuma, K; Sannomiya, Y; Sasaki, R; Shuto, T; Suico, MA; Sunamoto, H | 1 |
| Jayasinghe, K; Quinlan, C | 1 |
| Andreoli, S; Appel, GB; Bangalore, S; Block, GA; Chapman, AB; Chertow, GM; Chin, MP; Gibson, KL; Goldsberry, A; Iijima, K; Inker, LA; Knebelmann, B; Mariani, LH; Meyer, CJ; Nozu, K; O'Grady, M; Pergola, PE; Silva, AL; Stenvinkel, P; Torra, R; Warady, BA | 1 |
| Toto, RD | 1 |
| Baigent, C; Lennon, R | 1 |
| Briggs, JP; Hostetter, TH | 1 |
1 trial(s) available for oleanolic acid and Alport Syndrome
| Article | Year |
|---|---|
Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome.
Topics: Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Nephritis, Hereditary; Oleanolic Acid; Research Design; Treatment Outcome | 2021 |
5 other study(ies) available for oleanolic acid and Alport Syndrome
| Article | Year |
|---|---|
Novel Keap1-Nrf2 Protein-Protein Interaction Inhibitor UBE-1099 Ameliorates Progressive Phenotype in Alport Syndrome Mouse Model.
Topics: Animals; Disease Models, Animal; Kelch-Like ECH-Associated Protein 1; Mice; Nephritis, Hereditary; NF-E2-Related Factor 2; Oleanolic Acid; Phenotype; Renal Insufficiency, Chronic | 2022 |
Bardoxolone Methyl for Alport Syndrome: Opportunities and Challenges.
Topics: Collagen Type IV; Hematuria; Humans; Kidney; Nephritis, Hereditary; Oleanolic Acid | 2022 |
Bardoxolone-the Phoenix?
Topics: Anti-Inflammatory Agents; Clinical Trials as Topic; Diabetic Nephropathies; Disease Progression; Glomerular Filtration Rate; Heart Failure; Humans; Nephritis, Hereditary; Oleanolic Acid; Renal Insufficiency, Chronic | 2018 |
Should We Increase GFR with Bardoxolone in Alport Syndrome?
Topics: Albuminuria; Anti-Inflammatory Agents; Clinical Trials as Topic; Diabetic Nephropathies; Disease Progression; Glomerular Filtration Rate; Heart Failure; Humans; Nephritis, Hereditary; Oleanolic Acid; Renal Insufficiency, Chronic | 2018 |
Editorial Note: From Both Sides Now.
Topics: Humans; Nephritis, Hereditary; Oleanolic Acid | 2018 |